Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
4,043,321
-
Total 13F shares
-
25,827
-
Share change
-
+25,827
-
Total reported value
-
$94,139
-
Price per share
-
$3.65
-
Number of holders
-
13
-
Value change
-
+$94,139
-
Number of buys
-
13
Institutional Holders of BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (BCTX) as of Q1 2025
As of 31 Mar 2025,
BriaCell Therapeutics Corp. - Common Stock, $0.01 par value (BCTX) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,827 shares.
The largest 10 holders included
UBS Group AG, GROUP ONE TRADING LLC, ROYAL BANK OF CANADA, NATIONAL BANK OF CANADA /FI/, SBI Securities Co., Ltd., MORGAN STANLEY, Concord Wealth Partners, TD Waterhouse Canada Inc., OSAIC HOLDINGS, INC., and HHM Wealth Advisors, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.